Fate Therapeutics FATE Cash Flow Statement (2012-2026)

NASDAQ FATE
$2.38 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Fate Therapeutics Quarterly Cash Flow Statement

Periods 56 quarters
Latest Jun 2026

Fate Therapeutics reported cash from operations of -$23.40M and free cash flow of -$23.48M for the quarter ended Jun 2026, up 4.8% year over year. This cash flow statement covers 56 quarters of results from Sep 2012 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-54.33M-69.08M-74.05M-82.35M-84.60M-61.54M-24.90M-58.18M-46.58M-43.66M-46.92M-40.26M-47.94M-57.87M-37.94M-34.05M-32.16M-32.50M-31.13M-29.58M
Share-based Compensation
Gains from Sales and Divestitures
-0.94M-0.04M
Cash from Operations
-33.38M-70.29M-64.61M-53.16M-55.05M-75.39M-28.86M-28.49M-38.27M-36.64M-33.35M-32.31M-29.42M-27.80M-33.81M-24.59M-24.37M-23.31M-30.82M-23.40M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges
1.11M1.29M1.09M-0.33M0.78M1.13M7.20M
Depreciation & Amortization (CF)Depreciation & Amortization
1.52M2.26M2.76M2.96M3.19M4.88M4.19M4.47M4.74M4.90M4.82M4.72M4.61M4.85M3.33M3.28M3.23M3.06M2.92M2.78M
Change in Working Capital
Change in Receivables
-2.99M1.36M5.17M-0.72M-2.90M28.26M-24.98M-10.67M-1.30M0.29M-0.97M0.19M2.48M-0.59M-1.13M-1.01M-0.71M0.23M-0.21M-0.00M
Change in Accured Expenses
6.74M-10.38M-3.49M4.08M10.28M3.39M-20.39M-4.37M-2.28M-1.89M-4.51M0.32M1.87M0.66M-9.83M0.48M-0.55M0.86M-5.77M1.26M
Other Working Capital Changes
-5.85M-7.50M-3.50M11.63M2.79M7.41M-40.49M0.19M-0.82M-0.42M-4.57M3.49M-4.22M0.06M-3.92M0.79M-1.03M-1.01M0.20M-0.85M
Investing Activities
Capital Expenditures
14.73M18.37M10.08M10.13M8.68M6.68M3.21M2.20M0.56M0.18M0.09M0.05M0.49M0.10M1.20M1.36M2.20M1.19M0.24M0.08M
Sales of Property, Plant and Equipment
0.00M0.24M
Cash from Investing Activities
77.96M71.28M-7.03M40.29M80.38M53.11M9.34M33.17M24.80M45.35M17.31M-53.37M25.46M22.82M42.67M19.59M21.27M27.63M23.59M14.56M
Financing Activities
Other financing activities
3.13M
Debt Issuance and Repayment
Long-Term Debt Issuances
Long-Term Debt Repayments
Change in Capital Stock
Net Equity Issued and Repurchased
11.36M0.03M2.80M3.41M1.49M1.52M0.21M0.06M-0.18M75.19M-0.66M
Misc.
Cash from Financing Activities
7.94M3.42M2.80M3.41M1.49M1.52M0.21M0.06M-0.18M95.49M1.27M3.13M1.32M2.48M1.69M
Change in Cash
52.53M4.40M-68.84M-9.47M26.82M-20.76M-19.31M4.73M-13.47M8.54M79.45M-84.41M-3.96M-1.85M8.86M-3.67M-0.63M6.01M-7.24M-7.14M
Free Cash Flow
-48.11M-88.66M-74.70M-63.29M-63.72M-82.07M-32.07M-30.69M-38.84M-36.82M-33.44M-32.36M-29.91M-27.90M-35.01M-25.95M-26.58M-24.51M-31.06M-23.48M
Net Cash Flow
52.53M4.40M-68.84M-9.47M26.82M-20.76M-19.31M4.73M-13.47M8.54M79.45M-84.41M-3.96M-1.85M8.86M-3.67M-0.63M6.01M-7.24M-8.84M

Fate Therapeutics Cash Flow Statement API

Pull Fate Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=FATE&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY